DIVISLAB.NS Cash Flow
Divi's Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹24.60 Bn | ₹12.61 Bn | ₹16.53 Bn | ₹27.38 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-27.08 Bn | ₹-2.69 Bn | ₹-8.04 Bn | ₹-22.19 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-7.97 Bn | ₹-7.99 Bn | ₹-7.99 Bn | ₹-8.04 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹-10.45 Bn | ₹1.93 Bn | ₹0.50 Bn | ₹-2.85 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹12.15 Bn | ₹1.70 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from DIVISLAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).